CommentSepsis studies need new direction
References (8)
- et al.
Efficacy and safety of recombinant human activated protein C for severe sepsis
N Engl J Med
(2001) - Matsuyama K. Eisai's sepsis drug eritoran fails to save more lives in final-stage study....
Improving clinical trials in the critically ill: unique challenge—sepsis
Crit Care Med
(2009)- et al.
Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria
Intensive Care Med
(2012)
There are more references available in the full text version of this article.
Cited by (101)
Paeonol promotes the phagocytic ability of macrophages through confining HMGB1 to the nucleus
2020, International ImmunopharmacologySynthesis of bioactive lipid A and analogs
2020, Recent Trends in Carbohydrate Chemistry: Synthesis and Biomedical Applications of Glycans and GlycoconjugatesTanshinone IIA attenuates sepsis-induced immunosuppression and improves survival rate in a mice peritonitis model
2019, Biomedicine and Pharmacotherapy
Copyright © 2012 Elsevier Ltd. All rights reserved.